{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:24:25Z","timestamp":1755599065396},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Immune Based Ther Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>The protection, which some BCG vaccines could confer against the development of tuberculosis (TB) in childhood, might be indirectly reflected by the subsequent development of BCG immune response. The objectives of the study were to examine effectiveness and possible differences of post-vaccination reaction to a lyophilized BCG at different age groups and to evaluate its protection against TB in a decade's period.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We studied the post-vaccination PPD-skin reaction and scar formation at three different school levels, corresponding to ages of 6, 12 and 15 years old, vaccinated by a lyophilized BCG vaccine (Pasteur Institute), currently used in our country. During a 10-year follow up the reported TB cases in vaccinated and non-vaccinated adolescences up to 24-years old were analyzed and compared to the number of cumulative cases observed in the adult population of two neighboring territories (vaccinated and non-vaccinated).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results and Discussion<\/jats:title>\n                        <jats:p>There was a significant correlation (r<jats:sup>2<\/jats:sup> = 0.87, p &lt; 0.0001) between tuberculin induration and scar formation. There was no statistically significant difference between the three age groups (6, 12, and 15 year-old, respectively) in regard to the diameter of tuberculin induration or scar formation. Although 34% of 10-year later indurations were unpredictably related to the initial ones (increased or decreased), they were significantly correlated (r<jats:sup>2<\/jats:sup> = 0.45, p = 0.009). The relative percentage of TB for the 14\u201324 years-age group to the adult studied population was significantly lower among the immunized children compared to the non-immunized population of the same age group (17\/77, 22% vs. 71\/101, 70%, p &lt; .0001).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Our data suggest that the lyophilized BCG vaccine used for BCG programs at different age groups is equally effective and may confer satisfactory protection against tuberculosis in puberty.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1476-8518-3-1","type":"journal-article","created":{"date-parts":[[2005,4,2]],"date-time":"2005-04-02T06:14:11Z","timestamp":1112422451000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["BCG vaccination at three different age groups: response and effectiveness"],"prefix":"10.1186","volume":"3","author":[{"given":"George","family":"Briassoulis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Karabatsou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilis","family":"Gogoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Tsorva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,1]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0041-3879(81)90011-8","volume":"62","author":"Anonymous","year":"1981","unstructured":"Anonymous: Is BCG vaccination effective? [editorial]. Tubercle. 1981, 62: 219-221. 10.1016\/0041-3879(81)90011-8.","journal-title":"Tubercle"},{"key":"15_CR2","first-page":"37","volume":"5B","author":"HG Ten Dam","year":"1980","unstructured":"Ten Dam HG, Hitze KI: Does BCG vaccination protect the newborn and young infants?. Bull WHO. 1980, 5B: 37-41.","journal-title":"Bull WHO"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(84)90072-2","volume":"1","author":"HM Curtis","year":"1984","unstructured":"Curtis HM, Leck I, Bamford FN: Incidence of childhood tuberculosis after neonatal BCG vaccination. Lancet. 1984, 1: 145-148. 10.1016\/S0140-6736(84)90072-2.","journal-title":"Lancet"},{"key":"15_CR4","volume-title":"The school BCG vaccination programme","author":"Department of Health and Social Security","year":"1985","unstructured":"Department of Health and Social Security: The school BCG vaccination programme. 1985, London: DHSS, (DA(85)27)."},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/thx.39.5.321","volume":"39","author":"NW Horne","year":"1984","unstructured":"Horne NW: Control and prevention of tuberculosis: a code of practice [editorial]. Thorax. 1984, 39: 321-325.","journal-title":"Thorax"},{"key":"15_CR6","first-page":"402","volume":"134","author":"LS Farer","year":"1986","unstructured":"Farer LS: The current status of tuberculosis control efforts. Am Rev Respir Dis. 1986, 134: 402-407.","journal-title":"Am Rev Respir Dis"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","volume":"ii","author":"RDA Hart","year":"1977","unstructured":"Hart RDA, Sutherland I: BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. BMJ. 1977, ii: 293-295.","journal-title":"BMJ"},{"key":"15_CR8","first-page":"171","volume":"93","author":"GW Comstock","year":"1966","unstructured":"Comstock GW, Palmer CE: Long term results of BCG vaccination in the Southern United States. Am Rev Respir Dis. 1966, 93: 171-183.","journal-title":"Am Rev Respir Dis"},{"key":"15_CR9","first-page":"819","volume":"57","author":"Tuberculosis prevention trial","year":"1979","unstructured":"Tuberculosis prevention trial: Trial of BCG vaccines in South India for tuberculosis prevention. Bull WHO. 1979, 57: 819-827.","journal-title":"Bull WHO"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/bmj.286.6368.876","volume":"286","author":"Public Health Laboratory Service Communicable Disease Surveillance Centre","year":"1983","unstructured":"Public Health Laboratory Service Communicable Disease Surveillance Centre: BCG vaccination. BMJ. 1983, 286: 876-877.","journal-title":"BMJ"},{"key":"15_CR11","first-page":"46","volume":"72","author":"EN Sayi","year":"1995","unstructured":"Sayi EN, Mlay SM: Tuberculosis of the spine in children at Muhimbili Medical Centre, Dar es Salaam. East Afr Med J. 1995, 72: 46-48.","journal-title":"East Afr Med J"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1001\/jama.1983.03330410048027","volume":"249","author":"JD Clemens","year":"1983","unstructured":"Clemens JD, Chuong JJ, Feinstein AR: The BCG controversy. A methodological and statistical reappraisal. JAMA. 1983, 249: 2362-2369. 10.1001\/jama.249.17.2362.","journal-title":"JAMA"},{"key":"15_CR13","first-page":"56","volume":"110","author":"Research Centre (ICMR), Chennai","year":"1999","unstructured":"Research Centre (ICMR), Chennai: Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention. Tuberculosis Indian J Med Res. 1999, 110: 56-69.","journal-title":"Tuberculosis Indian J Med Res"},{"key":"15_CR14","first-page":"989","volume":"292","author":"JW Handfield","year":"1986","unstructured":"Handfield JW, Allan J, Windebank WJ: Sensitivity of neonates to tuberculin after BCG vaccination. BMJ. 1986, 292: 989-991.","journal-title":"BMJ"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1136\/adc.63.3.277","volume":"63","author":"GE Packe","year":"1988","unstructured":"Packe GE, Innes JA: Protective effect of BCG vaccination in infant Asians: a case-control study. Arch Dis Child. 1988, 63: 277-281.","journal-title":"Arch Dis Child"},{"key":"15_CR16","first-page":"73","volume":"1","author":"BCG","year":"1980","unstructured":"BCG: Bad news from India. Lancet. 1980, 1: 73-74.","journal-title":"Lancet"},{"key":"15_CR17","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1542\/peds.28.4.622","volume":"28","author":"SR Rosenthal","year":"1961","unstructured":"Rosenthal SR, Loewinsohn E, Graham ML, Liveright D, Thorne MG, Johnson V: BCG vaccination against tuberculosis in Chicago. A twenty year study statistically analysed. Pediatrics. 1961, 28: 622-641.","journal-title":"Pediatrics"},{"key":"15_CR18","unstructured":"Chamberlayne EC, (ed): Status of immunisation in tuberculosis in 1971. 1971, Bethesda: National Institutes of Health, (DHEW publication No (NIH) 72\u201368)."},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/00006454-198703000-00014","volume":"6","author":"V Romanus","year":"1987","unstructured":"Romanus V: Tuberculosis in Bacillus Calmette-Guerin-immunized and unimmunized children in Sweden: a ten-year evaluation following the cessation of general Bacillus Calmette-Guerin immunization of the newborn in 1975. Pediatr Infect Dis J. 1987, 6: 272-280.","journal-title":"Pediatr Infect Dis J"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0033-3506(86)80088-9","volume":"100","author":"KM Lumb","year":"1986","unstructured":"Lumb KM, Bandaranayake R, Beran PJ: BCG vaccination in infancy. Public Health. 1986, 100: 54-55.","journal-title":"Public Health"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1136\/adc.59.7.614","volume":"59","author":"H Grindulis","year":"1984","unstructured":"Grindulis H, Baynham MID, Scott PH, Thompson RA, Whalton BA: Tuberculin response two years after BCG vaccination at birth. Arch Dis Child. 1984, 59: 614-619.","journal-title":"Arch Dis Child"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1651-2227.1985.tb11030.x","volume":"74","author":"AH Dawodu","year":"1985","unstructured":"Dawodu AH: Tuberculin conversion following BCG vaccination in preterm infants. Acta Paediatr Scand. 1985, 74: 564-567.","journal-title":"Acta Paediatr Scand"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1164\/ajrccm.152.5.7582297","volume":"152","author":"FA al-Kassimi","year":"1995","unstructured":"al-Kassimi FA, al-Hajjaj MS, al-Orainey IO, Bamgboye EA: Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction?. Am J Respir Crit Care Med. 1995, 152: 1575-1578.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"15_CR24","first-page":"635","volume":"32","author":"A Aggarwal","year":"1995","unstructured":"Aggarwal A, Dutta AK: Timing and dose of BCG vaccination in infants as assessed by postvaccination tuberculin sensitivity. Indian Pediatr. 1995, 32 (6): 635-639.","journal-title":"Indian Pediatr"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0041-3879(87)90052-3","volume":"68","author":"JL Stanford","year":"1987","unstructured":"Stanford JL, Sheikh N, Bogle G, Baker C, Serries H, Mayo P: Protective effect of BCG in Admednagar, India. Tubercle. 1987, 68: 169-176. 10.1016\/0041-3879(87)90052-3.","journal-title":"Tubercle"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/00006454-198808000-00009","volume":"7","author":"RL Sepulveda","year":"1988","unstructured":"Sepulveda RL, Burr C, Ferrer X, Sorensen RU: Booster effect of tuberculin testing in healthy 6-year-old school children vaccinated with Bacillus Calmette-Guerin at birth in Santiago, Chile. Pediatr Infect Dis. 1988, 7: 578-581.","journal-title":"Pediatr Infect Dis"},{"key":"15_CR27","first-page":"962","volume":"3","author":"PE Fine","year":"1999","unstructured":"Fine PE, Bruce J, Ponnighaus JM, Nkhosa P, Harawa A, Vynnycky E: Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis. 1999, 3: 962-975.","journal-title":"Int J Tuberc Lung Dis"},{"key":"15_CR28","first-page":"442","volume-title":"Infectious diseases of children","author":"S Krugman","year":"1981","unstructured":"Krugman S, Katz JL: Infectious diseases of children. 1981, St Luis, Toronto, London: CVMosby Co, 442-443. Seventh","edition":"Seventh"},{"key":"15_CR29","first-page":"631","volume":"58","author":"S Landi","year":"1986","unstructured":"Landi S, Ashley MJ: The significance of a dual skin test with PPD and PPD-B in humans after BCG vaccination. Dev Biol Stand. 1986, 58: 631-636.","journal-title":"Dev Biol Stand"},{"key":"15_CR30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1183\/09031936.93.03020187","volume":"3","author":"MA Shaaban","year":"1990","unstructured":"Shaaban MA, Abdul Ati M, Bahr GM, Stanford JL, Lockwood DN, McManus IC: Revaccination with BCG: its effects on skin tests in Kuwaiti senior school chidlren. Eur Respir J. 1990, 3: 187-191.","journal-title":"Eur Respir J"},{"key":"15_CR31","first-page":"1445","volume":"28","author":"Anonymous","year":"1980","unstructured":"Anonymous: BCG vaccination in the newborn [editorial]. BMJ. 1980, 28: 1445-1446.","journal-title":"BMJ"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0041-3879(86)90016-4","volume":"67","author":"O Tidjani","year":"1986","unstructured":"Tidjani O, Amedone A, TenDam HG: The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community. Tubercle. 1986, 67: 269-281. 10.1016\/0041-3879(86)90016-4.","journal-title":"Tubercle"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2105\/AJPH.76.7.783","volume":"76","author":"T Kue Young","year":"1986","unstructured":"Kue Young T, Hershfield ES: A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians. Am J Public Health. 1986, 76: 783-786.","journal-title":"Am J Public Health"},{"key":"15_CR34","first-page":"507","volume-title":"Textbook of pulmonary diseases","author":"Wolinsky E Tuberculosis","year":"1983","unstructured":"Wolinsky E Tuberculosis: Textbook of pulmonary diseases. Edited by: Baum GE, Wolinsky E. 1983, Boston, Toronto: Little Brown Co, 507-572. 3","edition":"3"},{"issue":"4","key":"15_CR35","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1542\/peds.112.4.e298","volume":"112","author":"EM Santiago","year":"2003","unstructured":"Santiago EM, Lawson E, Gillenwater K, Kalangi S, Lescano AG, Du Quella G, Cummings K, Cabrera L, Torres C, Gilman RH: A prospective study of bacillus Calmette-Guerin scar formation and tuberculin skin test reactivity in infants in Lima, Peru. Pediatrics. 2003, 112 (4): e298-e298. 10.1542\/peds.112.4.e298.","journal-title":"Pediatrics"},{"issue":"6","key":"15_CR36","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0962-8479(92)90035-I","volume":"73","author":"JL Stanford","year":"1992","unstructured":"Stanford JL, Tala-Heikkila M: Good concordance between two batches of new tuberculin in the Mantoux test. Tuber Lung Dis. 1992, 73 (6): 326-329. 10.1016\/0962-8479(92)90035-I.","journal-title":"Tuber Lung Dis"},{"key":"15_CR37","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/bmj.288.6416.564","volume":"288","author":"CL Miller","year":"1984","unstructured":"Miller CL, Morris J, Pollock TM: PHLS inquiry into current BCG vaccination policy. BMJ. 1984, 288: 564-","journal-title":"BMJ"},{"key":"15_CR38","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1086\/426434","volume":"40","author":"F Tissot","year":"2005","unstructured":"Tissot F, Zanetti G, Francioli P, Zellweger JP, Zysset F: Influence of bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size?. Clin Infect Dis. 2005, 40: 211-217. 10.1086\/426434.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"15_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0962-8479(92)90061-N","volume":"73","author":"M Tala-Heikkila","year":"1992","unstructured":"Tala-Heikkila M, Nurmela T, Misljenovic O, Bleiker MA, Tala E: Sensitivity to PPD tuberculin and M. scrofulaceum sensitin in schoolchildren BCG vaccinated at birth. Tuber Lung Dis. 1992, 73 (2): 87-93. 10.1016\/0962-8479(92)90061-N.","journal-title":"Tuber Lung Dis"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0041-3879(87)90006-7","volume":"68","author":"JL Stanford","year":"1987","unstructured":"Stanford JL, Cunningham F, Pilkington A, Sargeant I, Series H, Bhatti N, Bennett E, Mehrotra ML: A prospective study of BCG given to young children in Agra, India- a region of high contact with enviromental mycobacteria. Tubercle. 1987, 68: 39-49. 10.1016\/0041-3879(87)90006-7.","journal-title":"Tubercle"},{"key":"15_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1046\/j.1440-1843.1999.00198.x","volume":"4","author":"LY Lao","year":"1999","unstructured":"Lao LY, De Guia T: Tuberculin skin testing: determinants and reaction. Respirology. 1999, 4: 311-317. 10.1046\/j.1440-1843.1999.00198.x.","journal-title":"Respirology"},{"key":"15_CR42","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1542\/peds.36.4.624","volume":"36","author":"M Lifschitz","year":"1965","unstructured":"Lifschitz M: Value of the tuberculin skin test as a screening test for tuberculosis among BCG vaccinated children. Pediatrics. 1965, 36: 624-627.","journal-title":"Pediatrics"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/00006454-198311000-00007","volume":"2","author":"RL Nemir","year":"1983","unstructured":"Nemir RL, Teichner A: Management of tuberculin reactors in children and adolescents previously vaccinated with BCG. Pediatr Infect Dis. 1983, 2: 446-451.","journal-title":"Pediatr Infect Dis"},{"issue":"2","key":"15_CR44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/0962-8479(95)90553-7","volume":"76","author":"H Johnson","year":"1995","unstructured":"Johnson H, Lee B, Doherty E, Kelly E, McDonnell T: Tuberculin sensitivity and the BCG scar in tuberculosis contacts. Tuber Lung Dis. 1995, 76 (2): 122-125. 10.1016\/0962-8479(95)90553-7.","journal-title":"Tuber Lung Dis"},{"key":"15_CR45","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/CDLI.6.6.934-937.1999","volume":"6","author":"PD Johnson","year":"1999","unstructured":"Johnson PD, Stuart RL, Grayson ML, Olden D, Clancy A, Ravn P, Andersen P, Britton WJ, Rothel JS: Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol. 1999, 6: 934-937.","journal-title":"Clin Diagn Lab Immunol"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/adc.57.10.734","volume":"57","author":"Medical Research Council Tuberculosis and Chest Diseases Unit","year":"1982","unstructured":"Medical Research Council Tuberculosis and Chest Diseases Unit: Tuberculosis in children in a national survey of notifications in England and Wales, 1978\u20131979. Arch Dis Child. 1982, 57: 734-741.","journal-title":"Arch Dis Child"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1164\/ajrccm.154.1.8680692","volume":"154","author":"GW Comstock","year":"1996","unstructured":"Comstock GW: Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction?. Am J Respir Crit Care Med. 1996, 154: 263-264.","journal-title":"Am J Respir Crit Care Med"},{"key":"15_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0962-8479(96)90076-3","volume":"77","author":"P Miret-Cuadras","year":"1996","unstructured":"Miret-Cuadras P, Pina-Gutierrez JM, Juncosa S: Tuberculin reactivity in Bacillus Calmette-Guerin vaccinated subjects. Tuber Lung Dis. 1996, 77: 52-58. 10.1016\/S0962-8479(96)90076-3.","journal-title":"Tuber Lung Dis"},{"key":"15_CR49","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/bmj.291.6496.658","volume":"291","author":"Medical Research Council Tuberculosis and Chest Diseases Unit","year":"1985","unstructured":"Medical Research Council Tuberculosis and Chest Diseases Unit: National survey of notifications of tuberculosis in England and Wales in 1983. BMJ. 1985, 291: 658-661.","journal-title":"BMJ"},{"issue":"2","key":"15_CR50","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1128\/IAI.68.2.791-795.2000","volume":"68","author":"L Brandt","year":"2000","unstructured":"Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P: ESAT-6 Subunit Vaccination against Mycobacterium tuberculosis. Infect Immun. 2000, 68 (2): 791-795. 10.1128\/IAI.68.2.791-795.2000.","journal-title":"Infect Immun"},{"key":"15_CR51","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0764-4469(00)87192-9","volume":"322","author":"J Hess","year":"1999","unstructured":"Hess J, Kaufmann SH: Development of novel tuberculosis vaccines. C R Acad Sci III. 1999, 322: 953-958.","journal-title":"C R Acad Sci III"}],"container-title":["Journal of Immune Based Therapies and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-8518-3-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1476-8518-3-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-8518-3-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:02:03Z","timestamp":1728306123000},"score":1,"resource":{"primary":{"URL":"https:\/\/jibtherapies.biomedcentral.com\/articles\/10.1186\/1476-8518-3-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,1]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,12]]}},"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.1186\/1476-8518-3-1","relation":{},"ISSN":["1476-8518"],"issn-type":[{"type":"electronic","value":"1476-8518"}],"subject":[],"published":{"date-parts":[[2005,4,1]]},"assertion":[{"value":"13 December 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1"}}